89Zr-immuno-PET is an attractive option for the in vivo evaluation of monoclonal antibodies (mAbs). For the coupling of 89Zr to monoclonal antibodies several conjugation strategies are available all using desferrioxamine as chelate. Here we discuss the production of 89Zr, the available methods for coupling of 89Zr via desferrioxamine to mAbs, and the evaluation of 89Zr-mAb conjugates in preclinical and clinical studies
Selection of the right drug for the right patient is a promising approach to increase clinical benef...
© 2018 Dr. Stacey Erin RuddPositron emission tomography (PET) is a medical diagnostic imaging techni...
Presently, hundreds of monoclonal antibodies (mAbs) and mAb fragments are under clinical development...
Immuno-positron emission tomography (immunoPET) with 89Zr-labeled antibodies has shown great potenti...
International audienceImmuno-positron emission tomography (immuno-PET) with Zr-89-labeled antibodies...
Positron emission tomography (PET) with 89Zr-labeled monoclonal antibodies (mAbs) or other targeted ...
Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access)Immuno-positron...
A method to label monoclonal antibodies (MAbs) with Zr-88 and Zr-89 has been developed and tested on...
Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visu...
Immuno-PET as a scouting procedure before radioimmuno-therapy (RIT) aims at confirming tumor targeti...
The identification of molecular drivers of disease and the compelling rise of biotherapeutics have i...
Targeted therapies hold great promise for cancer treatment and may exhibit even greater efficacy whe...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Dozens of monoclonal antibodies (mAbs) have been approved for clinical use, and hundreds more are un...
Item does not contain fulltextImmuno-PET as a scouting procedure before radioimmunotherapy (RIT) aim...
Selection of the right drug for the right patient is a promising approach to increase clinical benef...
© 2018 Dr. Stacey Erin RuddPositron emission tomography (PET) is a medical diagnostic imaging techni...
Presently, hundreds of monoclonal antibodies (mAbs) and mAb fragments are under clinical development...
Immuno-positron emission tomography (immunoPET) with 89Zr-labeled antibodies has shown great potenti...
International audienceImmuno-positron emission tomography (immuno-PET) with Zr-89-labeled antibodies...
Positron emission tomography (PET) with 89Zr-labeled monoclonal antibodies (mAbs) or other targeted ...
Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access)Immuno-positron...
A method to label monoclonal antibodies (MAbs) with Zr-88 and Zr-89 has been developed and tested on...
Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visu...
Immuno-PET as a scouting procedure before radioimmuno-therapy (RIT) aims at confirming tumor targeti...
The identification of molecular drivers of disease and the compelling rise of biotherapeutics have i...
Targeted therapies hold great promise for cancer treatment and may exhibit even greater efficacy whe...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Dozens of monoclonal antibodies (mAbs) have been approved for clinical use, and hundreds more are un...
Item does not contain fulltextImmuno-PET as a scouting procedure before radioimmunotherapy (RIT) aim...
Selection of the right drug for the right patient is a promising approach to increase clinical benef...
© 2018 Dr. Stacey Erin RuddPositron emission tomography (PET) is a medical diagnostic imaging techni...
Presently, hundreds of monoclonal antibodies (mAbs) and mAb fragments are under clinical development...